{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Minneapolis",
      "state": "MN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "94275",
      "recalling_firm": "IntegraDose Compounding Services LLC",
      "address_1": "719 Kasota Ave Se",
      "address_2": "",
      "postal_code": "55414-2842",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the U.S",
      "recall_number": "D-0432-2024",
      "product_description": "fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-6030-1",
      "product_quantity": "187 cassettes",
      "reason_for_recall": "Lack of Assurance of Sterility: leaking bags",
      "recall_initiation_date": "20240322",
      "center_classification_date": "20240403",
      "report_date": "20240410",
      "code_info": "Lot#: 20231020FEN-1, Exp: 04/17/2024",
      "more_code_info": ""
    }
  ]
}